In the present study, the expression levels of MAZ increased steadily from nonbone metastatic PCa tissues and bone metastatic PCa tissues to metastatic bone tissues, and high expression of MAZ was positively correlated with advanced clinicopathological characteristics and poor overall and bone metastasis-free survival in PCa patients. The gene discussed is MAZ; the disease is posterior cortical atrophy.